| #42 |
Juan Roa |
Futurewei Technologies |
1 |
| #42 |
Daniel Hall |
Sanofi |
1 |
| #42 |
Douglas Lund |
Heat Wave Technologies |
1 |
| #42 |
Curtis Goedde |
Ericsson |
1 |
| #42 |
Ankur S. Kulshrestha |
Becton, Dickinson And |
1 |
| #42 |
David A. Brain |
Fmc |
1 |
| #42 |
J. Alex Bates |
Bristol-Myers Squibb |
1 |
| #42 |
Lyn Leshe |
The Bank Of New York Mellon |
1 |
| #42 |
Barbara Porter |
Colgate-Palmolive |
1 |
| #42 |
Zhuming Zhang |
Hoffmann-La Roche |
1 |
| #42 |
Jian-Xie Chen |
Arqule |
1 |
| #42 |
Shiwei Tao |
Bristol-Myers Squibb |
1 |
| #42 |
Kiran Arun Karkhanis |
Morgan Stanley Services Group |
1 |
| #42 |
Michael N. Ferrara, JR. |
Omnitracs |
1 |
| #42 |
Sandra V. HATCHER |
Bristol-Myers Squibb |
1 |
| #42 |
Mateusz W. Szela |
AT&T |
1 |
| #42 |
Alla Shtabnaya |
Go!Foton |
1 |
| #42 |
David Michael Lutness |
Glaxosmithkline |
1 |
| #42 |
Srinivas Kodali |
Pfizer |
1 |
| #42 |
Gustavo Adolfo Ledezma |
GE |
1 |
| #42 |
Gabriel Olochwoszcz |
Ibiquity Digital |
1 |
| #42 |
James K. Choe |
Verizon |
1 |
| #42 |
Stephan Wielandy |
Lgs Innovations |
1 |
| #42 |
Alexander Marra |
Crestron Electronics |
1 |
| #42 |
Howard Loonan |
— |
1 |
| #42 |
Kevin M. Belyk |
Merck |
1 |
| #42 |
Yongxi Tan |
Futurewei Technologies |
1 |
| #42 |
Kevin Weadock |
Johnson & Johnson |
1 |
| #42 |
Andrea Eodice |
Henkel Ag & Co. Kgaa |
1 |
| #42 |
Richard Grotyohann |
Church & Dwight Co. |
1 |
| #42 |
Shyam T. Shyamalan |
Verizon |
1 |
| #42 |
Boris Shekunov |
Ferro |
1 |
| #42 |
James A. Flint |
Johnson & Johnson |
1 |
| #42 |
Hui Huang |
Bioarray Solutions |
1 |
| #42 |
Ricardo Couso |
Colgate-Palmolive |
1 |
| #42 |
Rajendra K. Damle |
Verizon |
1 |
| #42 |
Tracie L. Owens |
ExxonMobil |
1 |
| #42 |
Robert O. Cook |
Map Pharmaceuticals |
1 |
| #42 |
Vipul Dave |
Cordis |
1 |
| #42 |
Bhaskara Rao Nallaganchu |
Oncoceutics |
1 |
| #42 |
Hengpeng Wu |
Az Electronic Materials Usa |
1 |
| #42 |
David A. Duque |
Alcatel Lucent |
1 |
| #42 |
Bradley Drew Turock |
Therap Services |
1 |
| #42 |
Ravikumar Pattabiraman |
Verizon |
1 |
| #42 |
Anthony Pusateri |
Pharming Intellectual Property B.V. |
1 |
| #42 |
Ian M. Page |
National Research Development |
1 |
| #42 |
John Edward Cave, Jr. |
— |
1 |
| #42 |
Neil L. Rodriguez |
Lifecell |
1 |
| #42 |
Gregory Koll |
Johnson & Johnson |
1 |
| #42 |
Penn L. Pfautz |
AT&T |
1 |